OpenScience.ink

3 weeks ago • European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Hearing and balance side effects reported for GLP-1 receptor drugs: A study using FDA safety dataAudiovestibular adverse event reporting profiles of GLP-1 receptor agonists: A case-case pharmacovigilance study using FDA AEMS data.

📖 Top 30% JournalArticle

3 weeks ago • Advances in therapy

Patterns of Blood Sugar Treatments That Protect Heart and Kidney in Type 2 Diabetes Based on Real-World Patient GroupsCardiorenal Protective Glucose-Lowering Treatment Patterns in Type 2 Diabetes Mellitus Based on a Real-World Study: A Clinical Phenotype Cluster Analysis.

📖 Top 20% JournalArticle

3 weeks ago • The European respiratory journal

GLP-1 Treatments for Lung DiseasesGLP-1-based therapies in lung diseases.

🥈 Top 2% JournalArticle

3 weeks ago • Kidney research and clinical practice

Combined empagliflozin and liraglutide treatment may protect the pancreas and kidneys from tacrolimus damage by reducing oxidative stressCombined empagliflozin and liraglutide therapy protects against tacrolimus-induced pancreatic and renal injury associated with oxidative stress reduction.

📖 Top 20% JournalArticle

3 weeks ago • Obesity pillars

Challenges and high costs of starting glucagon-like peptide-1 therapy in young adultsHope, hype, and high costs: Navigating glucagon-like Peptide-1 based therapy initiation among young adults.

📖 Top 20% JournalArticle

3 weeks ago • JACC. Advances

Heart Risk in Heart Attack Patients with Overweight or Obesity Eligible for SELECT Treatment in Western DenmarkCardiovascular Risk in SELECT-Eligible MI Patients With Overweight or Obesity: The Western Denmark Heart Registry.

🎖️ Top 10% JournalArticle

3 weeks ago • Biology methods & protocols

Cardiometabolic benefits and side effects of low-dose semaglutide versus tirzepatideComparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatide.

📖 Top 30% JournalArticle

3 weeks ago • Haemophilia : the official journal of the World Federation of Hemophilia

Glucagon-Like Peptide-1 Signaling and Its Role in Joint Bleeding, Inflammation, and Cartilage Damage in HemophiliaImplications of Glucagon-Like Peptide-1 Signaling for Hemophilic Arthropathy, Joint Inflammation, and Cartilage Degeneration: A Narrative Review.

📖 Top 20% JournalArticle

3 weeks ago • Microbiological research

How gut bacteria and natural GLP-1 interact in chronic pancreatitis and possible repair processesThe gut-pancreas axis in chronic pancreatitis: Microbiota-endogenous GLP-1 interactions and candidate repair pathways.

🎖️ Top 10% JournalArticle

3 weeks ago • Journal of the American Pharmacists Association : JAPhA

Guidelines for using incretin-based treatments to manage weightA stewardship framework for incretin-based therapies in weight management.

📖 Top 30% JournalArticle

3 weeks ago • American journal of obstetrics and gynecology

How Birth Control and Diabetes Drugs Affect Metabolism and Reproductive HealthContraceptive use and GLP-1 receptor agonists: an intersection of metabolic and reproductive health.

🥉 Top 5% JournalArticle

3 weeks ago • Surgical endoscopy

Starting semaglutide six months after sleeve gastrectomy and its effects on long-term weight loss and metabolismThe impact of semaglutide initiated six months after laparoscopic sleeve gastrectomy on long-term weight loss and metabolic outcomes: single-center preliminary study.

📖 Top 20% JournalArticle

3 weeks ago • European journal of pharmacology

Tirzepatide reduces liver fat and inflammation in MASLD partly by blocking immune cell signalingTirzepatide alleviates hepatic steatosis and inflammation in MASLD partly through suppression of macrophage Dectin-1/Syk/NF-κB signaling.

📖 Top 20% JournalArticle

3 weeks ago • The Journal of clinical psychiatry

GLP-1 Receptor Agonists and Risk of Kidney Failure Treatment and Health Care Use in Bipolar Disorder Patients with Chronic Kidney DiseaseGLP-1 Receptor Agonists and Risk of Kidney Replacement Therapy and Health Care Utilization in Bipolar Disorder With Chronic Kidney Disease.

🎖️ Top 10% JournalArticle

3 weeks ago • European journal of pharmacology

How GLP-1 Receptors Work and the Benefits of Incretin-Based Drugs for Metabolic DiseasesGLP-1 receptor biology and the therapeutic role of incretin-based agonists in metabolic diseases.

📖 Top 20% JournalArticle

3 weeks ago • Diabetes

Olive Oil Before Sugar Slows Stomach Emptying and Lowers Blood Sugar in Mice Through Glucagon and GLP-1 SignalsOlive Oil Before Oral Glucose Delays Gastric Emptying and Lowers Glycemia Through Partially Redundant Glucagon and GLP-1 Signaling in Mice.

🥉 Top 5% JournalArticle

4 weeks ago • Journal of obesity & metabolic syndrome

The Role of Weight-Loss Surgery in the Age of Glucagon-Like Peptide-1 Treatments: Is Surgery Still Needed?The Future of Metabolic and Bariatric Surgery in the Glucagon-Like Peptide-1 Era: Has the Scalpel Become Obsolete?

🥉 Top 5% JournalArticle

4 weeks ago • JAMA network open

Use of GLP-1 Medicines in Adults with Diabetes and a History of CancerGLP-1 Receptor Agonist Use Among Adults With Diabetes and Cancer History.

🥈 Top 2% JournalArticle

4 weeks ago • Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Negative Mouth and Saliva Effects Linked to Glucagon-Like Peptide-1 Receptor Agonist MedicationsAdverse Oral and Salivary Effects Associated With Glucagon-Like Peptide-1 Receptor Agonists: Clinical Insights.

📖 Top 30% JournalArticle

4 weeks ago • Molecular metabolism

Specific brain neurons help control nausea caused by incretin hormones but do not affect appetite or weight lossParabrachial CGRP neurons mediate incretin-induced aversion and anti-aversion, but not anorexia or weight loss.

🥉 Top 5% JournalArticle

4 weeks ago • American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Use and prescribing patterns of incretin-like diabetes drugs in mostly Hispanic/Latino patients with type 2 diabetesIncretin Mimetics for Patients Living with Type 2 Diabetes in a Predominantly Hispanic/Latino Population: Analysis of Prescribing Frequency and Predictors of Use.

📖 Top 50% JournalArticle

4 weeks ago • American heart journal

Design and starting details of the CagriSema heart health outcomes trial (REDEFINE 3)Design and baseline characteristics of the CagriSema cardiovascular outcomes trial (REDEFINE 3).

🥉 Top 5% JournalArticle

4 weeks ago • Explore (New York, N.Y.)